Background
Cryptosporidiosis is a major cause of gastrointestinal diseases in humans and other vertebrates. Previous analyses of invasion-related proteins revealed that
Cryptosporidium parvum
,
Cryptosporidium hominis
, and
Cryptosporidium ubiquitum
mainly differed in copy numbers of secreted MEDLE proteins and insulinase-like proteases and sequences of mucin-type glycoproteins. Recently,
Cryptosporidium
chipmunk genotype I was identified as a novel zoonotic pathogen in humans. In this study, we sequenced its genome and conducted a comparative genomic analysis.
Results
The genome of
Cryptosporidium
chipmunk genotype I has gene content and organization similar to
C. parvum
and other intestinal
Cryptosporidium
species sequenced to date. A total of 3783 putative protein-encoding genes were identified in the genome, 3525 of which are shared by
Cryptosporidium
chipmunk genotype I and three major human-pathogenic
Cryptosporidium
species,
C. parvum
,
C. hominis
, and
Cryptosporidium meleagridis
. The metabolic pathways are almost identical among these four
Cryptosporidium
species. Compared with
C. parvum
, a major reduction in gene content in
Cryptosporidium
chipmunk genotype I is in the number of telomeric genes encoding MEDLE proteins (two instead of six) and insulinase-like proteases (one instead of two). Highly polymorphic genes between the two species are mostly subtelomeric ones encoding secretory proteins, most of which have higher dN/dS ratios and half are members of multiple gene families. In particular, two subtelomeric ABC transporters are under strong positive selection.
Conclusions
Cryptosporidium
chipmunk genotype I possesses genome organization, gene content, metabolic pathways and invasion-related proteins similar to the common human-pathogenic
Cryptosporidium
species, reaffirming its human-pathogenic nature. The loss of some subtelomeric genes encoding insulinase-like proteases and secreted MEDLE proteins and high sequence divergence in secreted pathogenesis determinants could contribute to the biological differences among human-pathogenic
Cryptosporidium
species.
Electronic supplementary material
The online version of this article (10.1186/s12864-019-5788-9) contains supplementary material, which is available to authorized users.